| MeSH term | MeSH ID | Detail |
|---|---|---|
| Zellweger Syndrome | D015211 | 39 associated lipids |
| Adenomatous Polyposis Coli | D011125 | 16 associated lipids |
| Adenomatous Polyps | D018256 | 4 associated lipids |
alpha-artemisic acid
Alpha-artemisic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 1126 references associated with alpha-artemisic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for alpha-artemisic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with alpha-artemisic acid
NCBI Entrez Crosslinks
All references with alpha-artemisic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Blask DE et al. | Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women. | 2009 | Integr Cancer Ther | pmid:20042410 |
| Kawakami Y et al. | Antiproliferative activity of guava leaf extract via inhibition of prostaglandin endoperoxide H synthase isoforms. | 2009 May-Jun | Prostaglandins Leukot. Essent. Fatty Acids | pmid:19457650 |
| Liu W et al. | Ex vivo oxidation in tissue and plasma assays of hydroxyoctadecadienoates: Z,E/E,E stereoisomer ratios. | 2010 | Chem. Res. Toxicol. | pmid:20423158 |
| Imaizumi S et al. | L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice. | 2010 | Drug Metab Lett | pmid:20642447 |
| Yuan H et al. | 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer. | 2010 | Thorax | pmid:20388757 |
| Liu SH et al. | Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals. | 2010 | Br. J. Pharmacol. | pmid:20649594 |
| Shureiqi I et al. | Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis. | 2010 | Cancer Prev Res (Phila) | pmid:20570882 |
| Li MY et al. | Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer. | 2010 | Am. J. Respir. Cell Mol. Biol. | pmid:20081051 |
| Ogawa E et al. | Epidermal FABP (FABP5) regulates keratinocyte differentiation by 13(S)-HODE-mediated activation of the NF-κB signaling pathway. | 2011 | J. Invest. Dermatol. | pmid:21068754 |
| Kämmerer I et al. | 13-hydroxy linoleic acid increases expression of the cholesterol transporters ABCA1, ABCG1 and SR-BI and stimulates apoA-I-dependent cholesterol efflux in RAW264.7 macrophages. | 2011 | Lipids Health Dis | pmid:22129452 |